nodes	percent_of_prediction	percent_of_DWPC	metapath
Zidovudine—CYP3A4—bone cancer	0.262	1	CbGaD
Zidovudine—ABCC5—Cisplatin—bone cancer	0.117	0.213	CbGbCtD
Zidovudine—UGT2B7—Epirubicin—bone cancer	0.0804	0.146	CbGbCtD
Zidovudine—SLC22A2—Cisplatin—bone cancer	0.0411	0.0745	CbGbCtD
Zidovudine—SLC22A11—Methotrexate—bone cancer	0.0393	0.0713	CbGbCtD
Zidovudine—SLC22A7—Methotrexate—bone cancer	0.0375	0.0679	CbGbCtD
Zidovudine—ABCC4—Methotrexate—bone cancer	0.0366	0.0664	CbGbCtD
Zidovudine—ABCG2—Carboplatin—bone cancer	0.0355	0.0644	CbGbCtD
Zidovudine—ABCG2—Cisplatin—bone cancer	0.0303	0.055	CbGbCtD
Zidovudine—SLC22A8—Methotrexate—bone cancer	0.0229	0.0415	CbGbCtD
Zidovudine—ABCG2—Doxorubicin—bone cancer	0.0203	0.0369	CbGbCtD
Zidovudine—ABCG2—Methotrexate—bone cancer	0.0197	0.0357	CbGbCtD
Zidovudine—SLC22A6—Methotrexate—bone cancer	0.0159	0.0289	CbGbCtD
Zidovudine—ALB—Methotrexate—bone cancer	0.0136	0.0246	CbGbCtD
Zidovudine—CYP2C9—Cisplatin—bone cancer	0.0113	0.0204	CbGbCtD
Zidovudine—ABCB1—Cisplatin—bone cancer	0.0109	0.0198	CbGbCtD
Zidovudine—ABCB1—Doxorubicin—bone cancer	0.00733	0.0133	CbGbCtD
Zidovudine—ABCB1—Methotrexate—bone cancer	0.0071	0.0129	CbGbCtD
Zidovudine—CYP3A4—Doxorubicin—bone cancer	0.00439	0.00796	CbGbCtD
Zidovudine—ABCB1—Constitutive Androstane Receptor Pathway—CYP3A4—bone cancer	0.000208	0.00231	CbGpPWpGaD
Zidovudine—Paraesthesia—Cisplatin—bone cancer	0.000199	0.00207	CcSEcCtD
Zidovudine—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—bone cancer	0.000198	0.0022	CbGpPWpGaD
Zidovudine—Dyspnoea—Cisplatin—bone cancer	0.000198	0.00205	CcSEcCtD
Zidovudine—Pancreatitis—Epirubicin—bone cancer	0.000196	0.00204	CcSEcCtD
Zidovudine—ABCC5—Fluoropyrimidine Activity—TP53—bone cancer	0.000194	0.00216	CbGpPWpGaD
Zidovudine—CYP2C9—Constitutive Androstane Receptor Pathway—CYP3A4—bone cancer	0.000194	0.00216	CbGpPWpGaD
Zidovudine—Breast disorder—Doxorubicin—bone cancer	0.000194	0.00201	CcSEcCtD
Zidovudine—Aspartate aminotransferase increased—Doxorubicin—bone cancer	0.000193	0.00201	CcSEcCtD
Zidovudine—Toxic epidermal necrolysis—Doxorubicin—bone cancer	0.000193	0.00201	CcSEcCtD
Zidovudine—Decreased appetite—Cisplatin—bone cancer	0.000193	0.002	CcSEcCtD
Zidovudine—ABCC5—NRF2 pathway—GSTP1—bone cancer	0.000192	0.00213	CbGpPWpGaD
Zidovudine—ABCC5—NRF2 pathway—TGFBR2—bone cancer	0.000192	0.00213	CbGpPWpGaD
Zidovudine—Nasopharyngitis—Doxorubicin—bone cancer	0.000192	0.00199	CcSEcCtD
Zidovudine—Gastrointestinal disorder—Cisplatin—bone cancer	0.000192	0.00199	CcSEcCtD
Zidovudine—Pancytopenia—Epirubicin—bone cancer	0.00019	0.00198	CcSEcCtD
Zidovudine—Pain—Cisplatin—bone cancer	0.00019	0.00197	CcSEcCtD
Zidovudine—Stevens-Johnson syndrome—Methotrexate—bone cancer	0.000189	0.00197	CcSEcCtD
Zidovudine—Dysuria—Epirubicin—bone cancer	0.000187	0.00195	CcSEcCtD
Zidovudine—Neutropenia—Epirubicin—bone cancer	0.000187	0.00195	CcSEcCtD
Zidovudine—Stomatitis—Methotrexate—bone cancer	0.000186	0.00193	CcSEcCtD
Zidovudine—Dysphagia—Doxorubicin—bone cancer	0.000185	0.00193	CcSEcCtD
Zidovudine—Influenza—Doxorubicin—bone cancer	0.000185	0.00193	CcSEcCtD
Zidovudine—Pollakiuria—Epirubicin—bone cancer	0.000185	0.00192	CcSEcCtD
Zidovudine—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—bone cancer	0.000185	0.00205	CbGpPWpGaD
Zidovudine—Sweating—Methotrexate—bone cancer	0.000183	0.0019	CcSEcCtD
Zidovudine—Feeling abnormal—Cisplatin—bone cancer	0.000183	0.0019	CcSEcCtD
Zidovudine—Haematuria—Methotrexate—bone cancer	0.000182	0.00189	CcSEcCtD
Zidovudine—Pancreatitis—Doxorubicin—bone cancer	0.000182	0.00189	CcSEcCtD
Zidovudine—Weight decreased—Epirubicin—bone cancer	0.000181	0.00188	CcSEcCtD
Zidovudine—Hepatobiliary disease—Methotrexate—bone cancer	0.000181	0.00187	CcSEcCtD
Zidovudine—ABCC5—Carbohydrate metabolism—ENO2—bone cancer	0.000181	0.00201	CbGpPWpGaD
Zidovudine—Epistaxis—Methotrexate—bone cancer	0.00018	0.00187	CcSEcCtD
Zidovudine—Agranulocytosis—Methotrexate—bone cancer	0.000178	0.00185	CcSEcCtD
Zidovudine—Stevens-Johnson syndrome—Epirubicin—bone cancer	0.000177	0.00184	CcSEcCtD
Zidovudine—Pancytopenia—Doxorubicin—bone cancer	0.000176	0.00183	CcSEcCtD
Zidovudine—TERT—Cell Cycle—CHEK2—bone cancer	0.000176	0.00195	CbGpPWpGaD
Zidovudine—Body temperature increased—Cisplatin—bone cancer	0.000175	0.00182	CcSEcCtD
Zidovudine—Neuropathy peripheral—Epirubicin—bone cancer	0.000175	0.00182	CcSEcCtD
Zidovudine—Stomatitis—Epirubicin—bone cancer	0.000174	0.00181	CcSEcCtD
Zidovudine—Jaundice—Epirubicin—bone cancer	0.000174	0.00181	CcSEcCtD
Zidovudine—Neutropenia—Doxorubicin—bone cancer	0.000173	0.0018	CcSEcCtD
Zidovudine—Dysuria—Doxorubicin—bone cancer	0.000173	0.0018	CcSEcCtD
Zidovudine—Hepatitis—Methotrexate—bone cancer	0.000171	0.00178	CcSEcCtD
Zidovudine—Sweating—Epirubicin—bone cancer	0.000171	0.00178	CcSEcCtD
Zidovudine—Pollakiuria—Doxorubicin—bone cancer	0.000171	0.00178	CcSEcCtD
Zidovudine—CYP2A6—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000171	0.0019	CbGpPWpGaD
Zidovudine—Haematuria—Epirubicin—bone cancer	0.00017	0.00177	CcSEcCtD
Zidovudine—Pharyngitis—Methotrexate—bone cancer	0.00017	0.00177	CcSEcCtD
Zidovudine—Urinary tract disorder—Methotrexate—bone cancer	0.000169	0.00176	CcSEcCtD
Zidovudine—Hepatobiliary disease—Epirubicin—bone cancer	0.000169	0.00175	CcSEcCtD
Zidovudine—Epistaxis—Epirubicin—bone cancer	0.000168	0.00175	CcSEcCtD
Zidovudine—Urethral disorder—Methotrexate—bone cancer	0.000168	0.00174	CcSEcCtD
Zidovudine—Weight decreased—Doxorubicin—bone cancer	0.000168	0.00174	CcSEcCtD
Zidovudine—Sinusitis—Epirubicin—bone cancer	0.000168	0.00174	CcSEcCtD
Zidovudine—SLC22A7—Fluoropyrimidine Activity—TP53—bone cancer	0.000167	0.00186	CbGpPWpGaD
Zidovudine—Agranulocytosis—Epirubicin—bone cancer	0.000167	0.00173	CcSEcCtD
Zidovudine—CYP3A4—Metapathway biotransformation—CYP4V2—bone cancer	0.000166	0.00185	CbGpPWpGaD
Zidovudine—Stevens-Johnson syndrome—Doxorubicin—bone cancer	0.000164	0.0017	CcSEcCtD
Zidovudine—Erythema multiforme—Methotrexate—bone cancer	0.000162	0.00168	CcSEcCtD
Zidovudine—Neuropathy peripheral—Doxorubicin—bone cancer	0.000162	0.00168	CcSEcCtD
Zidovudine—Stomatitis—Doxorubicin—bone cancer	0.000161	0.00167	CcSEcCtD
Zidovudine—Jaundice—Doxorubicin—bone cancer	0.000161	0.00167	CcSEcCtD
Zidovudine—Rhinitis—Epirubicin—bone cancer	0.000161	0.00167	CcSEcCtD
Zidovudine—Hepatitis—Epirubicin—bone cancer	0.00016	0.00167	CcSEcCtD
Zidovudine—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—bone cancer	0.000159	0.00177	CbGpPWpGaD
Zidovudine—Asthenia—Cisplatin—bone cancer	0.000159	0.00165	CcSEcCtD
Zidovudine—Pharyngitis—Epirubicin—bone cancer	0.000159	0.00165	CcSEcCtD
Zidovudine—Cardiac disorder—Methotrexate—bone cancer	0.000159	0.00165	CcSEcCtD
Zidovudine—Sweating—Doxorubicin—bone cancer	0.000158	0.00165	CcSEcCtD
Zidovudine—Urinary tract disorder—Epirubicin—bone cancer	0.000158	0.00164	CcSEcCtD
Zidovudine—Haematuria—Doxorubicin—bone cancer	0.000158	0.00164	CcSEcCtD
Zidovudine—Connective tissue disorder—Epirubicin—bone cancer	0.000158	0.00164	CcSEcCtD
Zidovudine—Urethral disorder—Epirubicin—bone cancer	0.000157	0.00163	CcSEcCtD
Zidovudine—ALB—Folate Metabolism—DHFR—bone cancer	0.000157	0.00174	CbGpPWpGaD
Zidovudine—Hepatobiliary disease—Doxorubicin—bone cancer	0.000156	0.00162	CcSEcCtD
Zidovudine—Epistaxis—Doxorubicin—bone cancer	0.000156	0.00162	CcSEcCtD
Zidovudine—Sinusitis—Doxorubicin—bone cancer	0.000155	0.00161	CcSEcCtD
Zidovudine—Mediastinal disorder—Methotrexate—bone cancer	0.000154	0.0016	CcSEcCtD
Zidovudine—Agranulocytosis—Doxorubicin—bone cancer	0.000154	0.0016	CcSEcCtD
Zidovudine—Chills—Methotrexate—bone cancer	0.000154	0.0016	CcSEcCtD
Zidovudine—Diarrhoea—Cisplatin—bone cancer	0.000152	0.00158	CcSEcCtD
Zidovudine—Erythema multiforme—Epirubicin—bone cancer	0.000152	0.00157	CcSEcCtD
Zidovudine—ABCC5—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000151	0.00168	CbGpPWpGaD
Zidovudine—Mental disorder—Methotrexate—bone cancer	0.00015	0.00156	CcSEcCtD
Zidovudine—Malnutrition—Methotrexate—bone cancer	0.000149	0.00155	CcSEcCtD
Zidovudine—Erythema—Methotrexate—bone cancer	0.000149	0.00155	CcSEcCtD
Zidovudine—Cardiac disorder—Epirubicin—bone cancer	0.000149	0.00155	CcSEcCtD
Zidovudine—TERT—Cell Cycle—BRCA2—bone cancer	0.000149	0.00165	CbGpPWpGaD
Zidovudine—Rhinitis—Doxorubicin—bone cancer	0.000149	0.00154	CcSEcCtD
Zidovudine—Hepatitis—Doxorubicin—bone cancer	0.000148	0.00154	CcSEcCtD
Zidovudine—Pharyngitis—Doxorubicin—bone cancer	0.000147	0.00153	CcSEcCtD
Zidovudine—Urinary tract disorder—Doxorubicin—bone cancer	0.000147	0.00152	CcSEcCtD
Zidovudine—Dysgeusia—Methotrexate—bone cancer	0.000146	0.00152	CcSEcCtD
Zidovudine—Connective tissue disorder—Doxorubicin—bone cancer	0.000146	0.00151	CcSEcCtD
Zidovudine—TERT—TGF-beta Signaling Pathway—TP53—bone cancer	0.000146	0.00162	CbGpPWpGaD
Zidovudine—Urethral disorder—Doxorubicin—bone cancer	0.000145	0.00151	CcSEcCtD
Zidovudine—UGT2B7—Biological oxidations—CYP3A4—bone cancer	0.000145	0.00161	CbGpPWpGaD
Zidovudine—Mediastinal disorder—Epirubicin—bone cancer	0.000145	0.0015	CcSEcCtD
Zidovudine—Back pain—Methotrexate—bone cancer	0.000144	0.0015	CcSEcCtD
Zidovudine—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000144	0.0016	CbGpPWpGaD
Zidovudine—Chills—Epirubicin—bone cancer	0.000144	0.00149	CcSEcCtD
Zidovudine—UGT2B7—Metapathway biotransformation—CYP3A4—bone cancer	0.000143	0.00159	CbGpPWpGaD
Zidovudine—SLC22A11—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000143	0.00159	CbGpPWpGaD
Zidovudine—CYP2C8—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000142	0.00158	CbGpPWpGaD
Zidovudine—UGT2B7—NRF2 pathway—GSTP1—bone cancer	0.000142	0.00157	CbGpPWpGaD
Zidovudine—UGT2B7—NRF2 pathway—TGFBR2—bone cancer	0.000142	0.00157	CbGpPWpGaD
Zidovudine—Vomiting—Cisplatin—bone cancer	0.000141	0.00146	CcSEcCtD
Zidovudine—Mental disorder—Epirubicin—bone cancer	0.00014	0.00146	CcSEcCtD
Zidovudine—Erythema multiforme—Doxorubicin—bone cancer	0.00014	0.00146	CcSEcCtD
Zidovudine—Rash—Cisplatin—bone cancer	0.00014	0.00145	CcSEcCtD
Zidovudine—Dermatitis—Cisplatin—bone cancer	0.00014	0.00145	CcSEcCtD
Zidovudine—Malnutrition—Epirubicin—bone cancer	0.00014	0.00145	CcSEcCtD
Zidovudine—Erythema—Epirubicin—bone cancer	0.00014	0.00145	CcSEcCtD
Zidovudine—Ill-defined disorder—Methotrexate—bone cancer	0.000138	0.00144	CcSEcCtD
Zidovudine—Anaemia—Methotrexate—bone cancer	0.000138	0.00143	CcSEcCtD
Zidovudine—Cardiac disorder—Doxorubicin—bone cancer	0.000138	0.00143	CcSEcCtD
Zidovudine—Flatulence—Epirubicin—bone cancer	0.000138	0.00143	CcSEcCtD
Zidovudine—ALB—Platelet degranulation—SPARC—bone cancer	0.000137	0.00153	CbGpPWpGaD
Zidovudine—Tension—Epirubicin—bone cancer	0.000137	0.00142	CcSEcCtD
Zidovudine—Dysgeusia—Epirubicin—bone cancer	0.000137	0.00142	CcSEcCtD
Zidovudine—Nervousness—Epirubicin—bone cancer	0.000136	0.00141	CcSEcCtD
Zidovudine—Back pain—Epirubicin—bone cancer	0.000135	0.0014	CcSEcCtD
Zidovudine—ABCC4—Fluoropyrimidine Activity—TP53—bone cancer	0.000135	0.0015	CbGpPWpGaD
Zidovudine—ABCC4—Platelet activation, signaling and aggregation—SPARC—bone cancer	0.000135	0.0015	CbGpPWpGaD
Zidovudine—Malaise—Methotrexate—bone cancer	0.000135	0.0014	CcSEcCtD
Zidovudine—Muscle spasms—Epirubicin—bone cancer	0.000134	0.00139	CcSEcCtD
Zidovudine—Vertigo—Methotrexate—bone cancer	0.000134	0.00139	CcSEcCtD
Zidovudine—Mediastinal disorder—Doxorubicin—bone cancer	0.000134	0.00139	CcSEcCtD
Zidovudine—Leukopenia—Methotrexate—bone cancer	0.000134	0.00139	CcSEcCtD
Zidovudine—Chills—Doxorubicin—bone cancer	0.000133	0.00138	CcSEcCtD
Zidovudine—ABCC4—NRF2 pathway—GSTP1—bone cancer	0.000133	0.00148	CbGpPWpGaD
Zidovudine—ABCC4—NRF2 pathway—TGFBR2—bone cancer	0.000133	0.00148	CbGpPWpGaD
Zidovudine—Nausea—Cisplatin—bone cancer	0.000132	0.00137	CcSEcCtD
Zidovudine—ALB—Response to elevated platelet cytosolic Ca2+—SPARC—bone cancer	0.000131	0.00145	CbGpPWpGaD
Zidovudine—ABCC5—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.00013	0.00145	CbGpPWpGaD
Zidovudine—Cough—Methotrexate—bone cancer	0.00013	0.00135	CcSEcCtD
Zidovudine—Mental disorder—Doxorubicin—bone cancer	0.00013	0.00135	CcSEcCtD
Zidovudine—SLC22A7—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.00013	0.00144	CbGpPWpGaD
Zidovudine—Ill-defined disorder—Epirubicin—bone cancer	0.00013	0.00135	CcSEcCtD
Zidovudine—Convulsion—Methotrexate—bone cancer	0.000129	0.00134	CcSEcCtD
Zidovudine—Malnutrition—Doxorubicin—bone cancer	0.000129	0.00134	CcSEcCtD
Zidovudine—Erythema—Doxorubicin—bone cancer	0.000129	0.00134	CcSEcCtD
Zidovudine—Anaemia—Epirubicin—bone cancer	0.000129	0.00134	CcSEcCtD
Zidovudine—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000129	0.00143	CbGpPWpGaD
Zidovudine—Flatulence—Doxorubicin—bone cancer	0.000127	0.00132	CcSEcCtD
Zidovudine—CYP2C19—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000127	0.00141	CbGpPWpGaD
Zidovudine—Myalgia—Methotrexate—bone cancer	0.000127	0.00132	CcSEcCtD
Zidovudine—Arthralgia—Methotrexate—bone cancer	0.000127	0.00132	CcSEcCtD
Zidovudine—Chest pain—Methotrexate—bone cancer	0.000127	0.00132	CcSEcCtD
Zidovudine—Tension—Doxorubicin—bone cancer	0.000127	0.00132	CcSEcCtD
Zidovudine—Dysgeusia—Doxorubicin—bone cancer	0.000126	0.00131	CcSEcCtD
Zidovudine—TERT—Signaling Pathways—RGS1—bone cancer	0.000126	0.0014	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—GRM4—bone cancer	0.000126	0.0014	CbGpPWpGaD
Zidovudine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—bone cancer	0.000126	0.00131	CcSEcCtD
Zidovudine—Malaise—Epirubicin—bone cancer	0.000126	0.00131	CcSEcCtD
Zidovudine—Discomfort—Methotrexate—bone cancer	0.000125	0.0013	CcSEcCtD
Zidovudine—Nervousness—Doxorubicin—bone cancer	0.000125	0.0013	CcSEcCtD
Zidovudine—Vertigo—Epirubicin—bone cancer	0.000125	0.0013	CcSEcCtD
Zidovudine—Syncope—Epirubicin—bone cancer	0.000125	0.0013	CcSEcCtD
Zidovudine—Leukopenia—Epirubicin—bone cancer	0.000125	0.0013	CcSEcCtD
Zidovudine—Back pain—Doxorubicin—bone cancer	0.000125	0.0013	CcSEcCtD
Zidovudine—Muscle spasms—Doxorubicin—bone cancer	0.000124	0.00129	CcSEcCtD
Zidovudine—UGT2B7—Biological oxidations—GSTP1—bone cancer	0.000124	0.00138	CbGpPWpGaD
Zidovudine—SLC22A11—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000124	0.00137	CbGpPWpGaD
Zidovudine—ABCC4—Platelet activation, signaling and aggregation—GNA11—bone cancer	0.000123	0.00137	CbGpPWpGaD
Zidovudine—Confusional state—Methotrexate—bone cancer	0.000123	0.00127	CcSEcCtD
Zidovudine—Loss of consciousness—Epirubicin—bone cancer	0.000123	0.00127	CcSEcCtD
Zidovudine—UGT2B7—Metapathway biotransformation—GSTP1—bone cancer	0.000122	0.00136	CbGpPWpGaD
Zidovudine—Cough—Epirubicin—bone cancer	0.000122	0.00127	CcSEcCtD
Zidovudine—Anaphylactic shock—Methotrexate—bone cancer	0.000122	0.00126	CcSEcCtD
Zidovudine—Convulsion—Epirubicin—bone cancer	0.000121	0.00126	CcSEcCtD
Zidovudine—Ill-defined disorder—Doxorubicin—bone cancer	0.00012	0.00124	CcSEcCtD
Zidovudine—Nervous system disorder—Methotrexate—bone cancer	0.000119	0.00124	CcSEcCtD
Zidovudine—Anaemia—Doxorubicin—bone cancer	0.000119	0.00124	CcSEcCtD
Zidovudine—Thrombocytopenia—Methotrexate—bone cancer	0.000119	0.00124	CcSEcCtD
Zidovudine—Chest pain—Epirubicin—bone cancer	0.000119	0.00123	CcSEcCtD
Zidovudine—Myalgia—Epirubicin—bone cancer	0.000119	0.00123	CcSEcCtD
Zidovudine—Arthralgia—Epirubicin—bone cancer	0.000119	0.00123	CcSEcCtD
Zidovudine—Anxiety—Epirubicin—bone cancer	0.000118	0.00123	CcSEcCtD
Zidovudine—Skin disorder—Methotrexate—bone cancer	0.000118	0.00123	CcSEcCtD
Zidovudine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—bone cancer	0.000118	0.00123	CcSEcCtD
Zidovudine—ABCC5—Metabolism—NDUFA12—bone cancer	0.000118	0.00131	CbGpPWpGaD
Zidovudine—Hyperhidrosis—Methotrexate—bone cancer	0.000118	0.00122	CcSEcCtD
Zidovudine—Discomfort—Epirubicin—bone cancer	0.000117	0.00122	CcSEcCtD
Zidovudine—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000117	0.0013	CbGpPWpGaD
Zidovudine—CYP2C8—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000117	0.0013	CbGpPWpGaD
Zidovudine—Malaise—Doxorubicin—bone cancer	0.000116	0.00121	CcSEcCtD
Zidovudine—TERT—Disease—ENO2—bone cancer	0.000116	0.00129	CbGpPWpGaD
Zidovudine—Vertigo—Doxorubicin—bone cancer	0.000116	0.00121	CcSEcCtD
Zidovudine—Anorexia—Methotrexate—bone cancer	0.000116	0.00121	CcSEcCtD
Zidovudine—Syncope—Doxorubicin—bone cancer	0.000116	0.0012	CcSEcCtD
Zidovudine—CYP2C9—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000116	0.00129	CbGpPWpGaD
Zidovudine—Leukopenia—Doxorubicin—bone cancer	0.000116	0.0012	CcSEcCtD
Zidovudine—Confusional state—Epirubicin—bone cancer	0.000115	0.00119	CcSEcCtD
Zidovudine—Anaphylactic shock—Epirubicin—bone cancer	0.000114	0.00118	CcSEcCtD
Zidovudine—Oedema—Epirubicin—bone cancer	0.000114	0.00118	CcSEcCtD
Zidovudine—Loss of consciousness—Doxorubicin—bone cancer	0.000114	0.00118	CcSEcCtD
Zidovudine—Cough—Doxorubicin—bone cancer	0.000113	0.00117	CcSEcCtD
Zidovudine—Shock—Epirubicin—bone cancer	0.000112	0.00116	CcSEcCtD
Zidovudine—SLC22A7—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000112	0.00125	CbGpPWpGaD
Zidovudine—Convulsion—Doxorubicin—bone cancer	0.000112	0.00116	CcSEcCtD
Zidovudine—Nervous system disorder—Epirubicin—bone cancer	0.000112	0.00116	CcSEcCtD
Zidovudine—ABCC4—Platelet activation, signaling and aggregation—IL3—bone cancer	0.000112	0.00124	CbGpPWpGaD
Zidovudine—Thrombocytopenia—Epirubicin—bone cancer	0.000112	0.00116	CcSEcCtD
Zidovudine—Musculoskeletal discomfort—Methotrexate—bone cancer	0.000111	0.00115	CcSEcCtD
Zidovudine—Skin disorder—Epirubicin—bone cancer	0.000111	0.00115	CcSEcCtD
Zidovudine—TERT—Cell Cycle—CDK4—bone cancer	0.00011	0.00123	CbGpPWpGaD
Zidovudine—Hyperhidrosis—Epirubicin—bone cancer	0.00011	0.00114	CcSEcCtD
Zidovudine—Insomnia—Methotrexate—bone cancer	0.00011	0.00114	CcSEcCtD
Zidovudine—Myalgia—Doxorubicin—bone cancer	0.00011	0.00114	CcSEcCtD
Zidovudine—Chest pain—Doxorubicin—bone cancer	0.00011	0.00114	CcSEcCtD
Zidovudine—Arthralgia—Doxorubicin—bone cancer	0.00011	0.00114	CcSEcCtD
Zidovudine—Anxiety—Doxorubicin—bone cancer	0.00011	0.00114	CcSEcCtD
Zidovudine—TERT—Signaling Pathways—GRM1—bone cancer	0.000109	0.00122	CbGpPWpGaD
Zidovudine—Paraesthesia—Methotrexate—bone cancer	0.000109	0.00114	CcSEcCtD
Zidovudine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—bone cancer	0.000109	0.00113	CcSEcCtD
Zidovudine—SLC22A8—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000109	0.00121	CbGpPWpGaD
Zidovudine—Discomfort—Doxorubicin—bone cancer	0.000109	0.00113	CcSEcCtD
Zidovudine—Anorexia—Epirubicin—bone cancer	0.000109	0.00113	CcSEcCtD
Zidovudine—Dyspnoea—Methotrexate—bone cancer	0.000109	0.00113	CcSEcCtD
Zidovudine—Somnolence—Methotrexate—bone cancer	0.000108	0.00112	CcSEcCtD
Zidovudine—TERT—Disease—DHFR—bone cancer	0.000108	0.0012	CbGpPWpGaD
Zidovudine—TK1—Metabolism—ENO2—bone cancer	0.000108	0.0012	CbGpPWpGaD
Zidovudine—Dyspepsia—Methotrexate—bone cancer	0.000107	0.00111	CcSEcCtD
Zidovudine—Confusional state—Doxorubicin—bone cancer	0.000106	0.0011	CcSEcCtD
Zidovudine—Decreased appetite—Methotrexate—bone cancer	0.000106	0.0011	CcSEcCtD
Zidovudine—Oedema—Doxorubicin—bone cancer	0.000105	0.00109	CcSEcCtD
Zidovudine—Anaphylactic shock—Doxorubicin—bone cancer	0.000105	0.00109	CcSEcCtD
Zidovudine—Gastrointestinal disorder—Methotrexate—bone cancer	0.000105	0.00109	CcSEcCtD
Zidovudine—Fatigue—Methotrexate—bone cancer	0.000105	0.00109	CcSEcCtD
Zidovudine—ABCC4—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000105	0.00116	CbGpPWpGaD
Zidovudine—CYP2C19—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000104	0.00116	CbGpPWpGaD
Zidovudine—Pain—Methotrexate—bone cancer	0.000104	0.00108	CcSEcCtD
Zidovudine—Musculoskeletal discomfort—Epirubicin—bone cancer	0.000104	0.00108	CcSEcCtD
Zidovudine—Shock—Doxorubicin—bone cancer	0.000104	0.00108	CcSEcCtD
Zidovudine—Nervous system disorder—Doxorubicin—bone cancer	0.000103	0.00107	CcSEcCtD
Zidovudine—Thrombocytopenia—Doxorubicin—bone cancer	0.000103	0.00107	CcSEcCtD
Zidovudine—Insomnia—Epirubicin—bone cancer	0.000103	0.00107	CcSEcCtD
Zidovudine—Skin disorder—Doxorubicin—bone cancer	0.000102	0.00106	CcSEcCtD
Zidovudine—Paraesthesia—Epirubicin—bone cancer	0.000102	0.00106	CcSEcCtD
Zidovudine—Hyperhidrosis—Doxorubicin—bone cancer	0.000102	0.00106	CcSEcCtD
Zidovudine—Dyspnoea—Epirubicin—bone cancer	0.000102	0.00105	CcSEcCtD
Zidovudine—Somnolence—Epirubicin—bone cancer	0.000101	0.00105	CcSEcCtD
Zidovudine—Anorexia—Doxorubicin—bone cancer	0.0001	0.00104	CcSEcCtD
Zidovudine—Feeling abnormal—Methotrexate—bone cancer	0.0001	0.00104	CcSEcCtD
Zidovudine—Dyspepsia—Epirubicin—bone cancer	0.0001	0.00104	CcSEcCtD
Zidovudine—TK1—Metabolism—DHFR—bone cancer	9.98e-05	0.00111	CbGpPWpGaD
Zidovudine—Gastrointestinal pain—Methotrexate—bone cancer	9.95e-05	0.00103	CcSEcCtD
Zidovudine—Decreased appetite—Epirubicin—bone cancer	9.9e-05	0.00103	CcSEcCtD
Zidovudine—ABCG2—Fluoropyrimidine Activity—TP53—bone cancer	9.89e-05	0.0011	CbGpPWpGaD
Zidovudine—Gastrointestinal disorder—Epirubicin—bone cancer	9.84e-05	0.00102	CcSEcCtD
Zidovudine—Fatigue—Epirubicin—bone cancer	9.82e-05	0.00102	CcSEcCtD
Zidovudine—ABCC5—Metabolism—NT5C3A—bone cancer	9.78e-05	0.00109	CbGpPWpGaD
Zidovudine—Constipation—Epirubicin—bone cancer	9.74e-05	0.00101	CcSEcCtD
Zidovudine—Pain—Epirubicin—bone cancer	9.74e-05	0.00101	CcSEcCtD
Zidovudine—Urticaria—Methotrexate—bone cancer	9.67e-05	0.001	CcSEcCtD
Zidovudine—Abdominal pain—Methotrexate—bone cancer	9.62e-05	0.000999	CcSEcCtD
Zidovudine—Body temperature increased—Methotrexate—bone cancer	9.62e-05	0.000999	CcSEcCtD
Zidovudine—Musculoskeletal discomfort—Doxorubicin—bone cancer	9.6e-05	0.000997	CcSEcCtD
Zidovudine—TERT—Cell Cycle—RB1—bone cancer	9.6e-05	0.00107	CbGpPWpGaD
Zidovudine—Insomnia—Doxorubicin—bone cancer	9.53e-05	0.00099	CcSEcCtD
Zidovudine—CYP2C9—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	9.51e-05	0.00106	CbGpPWpGaD
Zidovudine—Paraesthesia—Doxorubicin—bone cancer	9.47e-05	0.000983	CcSEcCtD
Zidovudine—SLC22A8—Transmembrane transport of small molecules—TUBB2A—bone cancer	9.42e-05	0.00105	CbGpPWpGaD
Zidovudine—Dyspnoea—Doxorubicin—bone cancer	9.4e-05	0.000976	CcSEcCtD
Zidovudine—Feeling abnormal—Epirubicin—bone cancer	9.39e-05	0.000975	CcSEcCtD
Zidovudine—Somnolence—Doxorubicin—bone cancer	9.37e-05	0.000973	CcSEcCtD
Zidovudine—TK1—Metabolism—GNA11—bone cancer	9.33e-05	0.00104	CbGpPWpGaD
Zidovudine—Gastrointestinal pain—Epirubicin—bone cancer	9.32e-05	0.000967	CcSEcCtD
Zidovudine—Dyspepsia—Doxorubicin—bone cancer	9.28e-05	0.000964	CcSEcCtD
Zidovudine—Decreased appetite—Doxorubicin—bone cancer	9.16e-05	0.000952	CcSEcCtD
Zidovudine—SLC22A6—Transmembrane transport of small molecules—TUBB4B—bone cancer	9.11e-05	0.00101	CbGpPWpGaD
Zidovudine—Gastrointestinal disorder—Doxorubicin—bone cancer	9.1e-05	0.000945	CcSEcCtD
Zidovudine—CYP2A6—Biological oxidations—CYP3A4—bone cancer	9.09e-05	0.00101	CbGpPWpGaD
Zidovudine—Fatigue—Doxorubicin—bone cancer	9.09e-05	0.000944	CcSEcCtD
Zidovudine—Urticaria—Epirubicin—bone cancer	9.05e-05	0.00094	CcSEcCtD
Zidovudine—ABCC4—Transmembrane transport of small molecules—TUBB2A—bone cancer	9.03e-05	0.001	CbGpPWpGaD
Zidovudine—Pain—Doxorubicin—bone cancer	9.01e-05	0.000936	CcSEcCtD
Zidovudine—Constipation—Doxorubicin—bone cancer	9.01e-05	0.000936	CcSEcCtD
Zidovudine—Body temperature increased—Epirubicin—bone cancer	9.01e-05	0.000935	CcSEcCtD
Zidovudine—Abdominal pain—Epirubicin—bone cancer	9.01e-05	0.000935	CcSEcCtD
Zidovudine—CYP2A6—Fluoropyrimidine Activity—TP53—bone cancer	8.98e-05	0.000998	CbGpPWpGaD
Zidovudine—CYP2A6—NRF2 pathway—GSTP1—bone cancer	8.86e-05	0.000985	CbGpPWpGaD
Zidovudine—CYP2A6—NRF2 pathway—TGFBR2—bone cancer	8.86e-05	0.000985	CbGpPWpGaD
Zidovudine—Asthenia—Methotrexate—bone cancer	8.73e-05	0.000907	CcSEcCtD
Zidovudine—UGT2B7—Metabolism—NDUFA12—bone cancer	8.7e-05	0.000967	CbGpPWpGaD
Zidovudine—Feeling abnormal—Doxorubicin—bone cancer	8.69e-05	0.000902	CcSEcCtD
Zidovudine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—bone cancer	8.62e-05	0.000958	CbGpPWpGaD
Zidovudine—Gastrointestinal pain—Doxorubicin—bone cancer	8.62e-05	0.000895	CcSEcCtD
Zidovudine—Pruritus—Methotrexate—bone cancer	8.61e-05	0.000894	CcSEcCtD
Zidovudine—ABCG2—HIF-1-alpha transcription factor network—JUN—bone cancer	8.6e-05	0.000956	CbGpPWpGaD
Zidovudine—TK1—Metabolism—CYP3A4—bone cancer	8.46e-05	0.00094	CbGpPWpGaD
Zidovudine—Urticaria—Doxorubicin—bone cancer	8.37e-05	0.00087	CcSEcCtD
Zidovudine—Body temperature increased—Doxorubicin—bone cancer	8.33e-05	0.000865	CcSEcCtD
Zidovudine—Abdominal pain—Doxorubicin—bone cancer	8.33e-05	0.000865	CcSEcCtD
Zidovudine—Diarrhoea—Methotrexate—bone cancer	8.33e-05	0.000865	CcSEcCtD
Zidovudine—TERT—Cell Cycle—MDM2—bone cancer	8.18e-05	0.000909	CbGpPWpGaD
Zidovudine—Asthenia—Epirubicin—bone cancer	8.17e-05	0.000849	CcSEcCtD
Zidovudine—Pruritus—Epirubicin—bone cancer	8.06e-05	0.000837	CcSEcCtD
Zidovudine—Dizziness—Methotrexate—bone cancer	8.05e-05	0.000836	CcSEcCtD
Zidovudine—SLC22A6—Transmembrane transport of small molecules—TUBB2A—bone cancer	7.86e-05	0.000874	CbGpPWpGaD
Zidovudine—TERT—Disease—TGFBR2—bone cancer	7.81e-05	0.000868	CbGpPWpGaD
Zidovudine—Diarrhoea—Epirubicin—bone cancer	7.79e-05	0.00081	CcSEcCtD
Zidovudine—CYP2A6—Biological oxidations—GSTP1—bone cancer	7.78e-05	0.000864	CbGpPWpGaD
Zidovudine—Vomiting—Methotrexate—bone cancer	7.74e-05	0.000804	CcSEcCtD
Zidovudine—TERT—Signaling Pathways—SMO—bone cancer	7.71e-05	0.000857	CbGpPWpGaD
Zidovudine—Rash—Methotrexate—bone cancer	7.68e-05	0.000797	CcSEcCtD
Zidovudine—ABCG2—Transmembrane transport of small molecules—TUBB4B—bone cancer	7.67e-05	0.000852	CbGpPWpGaD
Zidovudine—Dermatitis—Methotrexate—bone cancer	7.67e-05	0.000796	CcSEcCtD
Zidovudine—Headache—Methotrexate—bone cancer	7.63e-05	0.000792	CcSEcCtD
Zidovudine—SLC22A2—Transmembrane transport of small molecules—TUBB4B—bone cancer	7.59e-05	0.000844	CbGpPWpGaD
Zidovudine—Asthenia—Doxorubicin—bone cancer	7.56e-05	0.000785	CcSEcCtD
Zidovudine—Dizziness—Epirubicin—bone cancer	7.53e-05	0.000782	CcSEcCtD
Zidovudine—Pruritus—Doxorubicin—bone cancer	7.46e-05	0.000775	CcSEcCtD
Zidovudine—CYP2C8—Arachidonic acid metabolism—PTGS2—bone cancer	7.39e-05	0.000821	CbGpPWpGaD
Zidovudine—Vomiting—Epirubicin—bone cancer	7.24e-05	0.000752	CcSEcCtD
Zidovudine—TK1—Metabolism—GSTP1—bone cancer	7.23e-05	0.000804	CbGpPWpGaD
Zidovudine—Nausea—Methotrexate—bone cancer	7.23e-05	0.000751	CcSEcCtD
Zidovudine—Diarrhoea—Doxorubicin—bone cancer	7.21e-05	0.000749	CcSEcCtD
Zidovudine—UGT2B7—Metabolism—NT5C3A—bone cancer	7.21e-05	0.000801	CbGpPWpGaD
Zidovudine—Rash—Epirubicin—bone cancer	7.18e-05	0.000746	CcSEcCtD
Zidovudine—Dermatitis—Epirubicin—bone cancer	7.18e-05	0.000745	CcSEcCtD
Zidovudine—Headache—Epirubicin—bone cancer	7.14e-05	0.000741	CcSEcCtD
Zidovudine—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—bone cancer	7.06e-05	0.000784	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—GNA11—bone cancer	7.05e-05	0.000784	CbGpPWpGaD
Zidovudine—Dizziness—Doxorubicin—bone cancer	6.97e-05	0.000724	CcSEcCtD
Zidovudine—ABCC4—Hemostasis—SPARC—bone cancer	6.94e-05	0.000771	CbGpPWpGaD
Zidovudine—Nausea—Epirubicin—bone cancer	6.77e-05	0.000703	CcSEcCtD
Zidovudine—Vomiting—Doxorubicin—bone cancer	6.7e-05	0.000696	CcSEcCtD
Zidovudine—Rash—Doxorubicin—bone cancer	6.65e-05	0.00069	CcSEcCtD
Zidovudine—Dermatitis—Doxorubicin—bone cancer	6.64e-05	0.00069	CcSEcCtD
Zidovudine—ABCG2—Transmembrane transport of small molecules—TUBB2A—bone cancer	6.62e-05	0.000736	CbGpPWpGaD
Zidovudine—Headache—Doxorubicin—bone cancer	6.6e-05	0.000686	CcSEcCtD
Zidovudine—CYP2C19—Arachidonic acid metabolism—PTGS2—bone cancer	6.6e-05	0.000733	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—ATF1—bone cancer	6.56e-05	0.000729	CbGpPWpGaD
Zidovudine—SLC22A2—Transmembrane transport of small molecules—TUBB2A—bone cancer	6.55e-05	0.000728	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—IL3—bone cancer	6.39e-05	0.000711	CbGpPWpGaD
Zidovudine—ABCC4—Hemostasis—GNA11—bone cancer	6.35e-05	0.000705	CbGpPWpGaD
Zidovudine—Nausea—Doxorubicin—bone cancer	6.26e-05	0.00065	CcSEcCtD
Zidovudine—CYP2C8—Biological oxidations—CYP3A4—bone cancer	6.21e-05	0.00069	CbGpPWpGaD
Zidovudine—CYP2C8—Metapathway biotransformation—CYP3A4—bone cancer	6.12e-05	0.000681	CbGpPWpGaD
Zidovudine—ALB—Platelet activation, signaling and aggregation—SPARC—bone cancer	6.09e-05	0.000677	CbGpPWpGaD
Zidovudine—CYP2C9—Arachidonic acid metabolism—PTGS2—bone cancer	6.02e-05	0.000669	CbGpPWpGaD
Zidovudine—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—bone cancer	6e-05	0.000667	CbGpPWpGaD
Zidovudine—ABCG2—Metabolism—NDUFA12—bone cancer	6e-05	0.000666	CbGpPWpGaD
Zidovudine—SLC22A2—Metabolism—NDUFA12—bone cancer	5.94e-05	0.00066	CbGpPWpGaD
Zidovudine—ABCC4—Hemostasis—IL3—bone cancer	5.76e-05	0.00064	CbGpPWpGaD
Zidovudine—ALB—Platelet activation, signaling and aggregation—GNA11—bone cancer	5.57e-05	0.000619	CbGpPWpGaD
Zidovudine—CYP2C19—Biological oxidations—CYP3A4—bone cancer	5.54e-05	0.000616	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—TGFBR2—bone cancer	5.47e-05	0.000608	CbGpPWpGaD
Zidovudine—CYP2C19—Metapathway biotransformation—CYP3A4—bone cancer	5.47e-05	0.000607	CbGpPWpGaD
Zidovudine—ABCB1—Integrated Pancreatic Cancer Pathway—EZH2—bone cancer	5.46e-05	0.000607	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—NDUFA12—bone cancer	5.45e-05	0.000606	CbGpPWpGaD
Zidovudine—TERT—Disease—KIT—bone cancer	5.33e-05	0.000592	CbGpPWpGaD
Zidovudine—CYP2C8—Biological oxidations—GSTP1—bone cancer	5.31e-05	0.00059	CbGpPWpGaD
Zidovudine—CYP2C8—Metapathway biotransformation—GSTP1—bone cancer	5.24e-05	0.000582	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—IGF1R—bone cancer	5.15e-05	0.000572	CbGpPWpGaD
Zidovudine—ABCC5—Disease—ENO2—bone cancer	5.11e-05	0.000568	CbGpPWpGaD
Zidovudine—CYP2C9—Biological oxidations—CYP3A4—bone cancer	5.05e-05	0.000562	CbGpPWpGaD
Zidovudine—ALB—Platelet activation, signaling and aggregation—IL3—bone cancer	5.05e-05	0.000561	CbGpPWpGaD
Zidovudine—TERT—Disease—BRAF—bone cancer	5.01e-05	0.000557	CbGpPWpGaD
Zidovudine—CYP2C9—Metapathway biotransformation—CYP3A4—bone cancer	4.98e-05	0.000554	CbGpPWpGaD
Zidovudine—ABCB1—Integrated Pancreatic Cancer Pathway—IL3—bone cancer	4.98e-05	0.000553	CbGpPWpGaD
Zidovudine—ABCG2—Metabolism—NT5C3A—bone cancer	4.97e-05	0.000552	CbGpPWpGaD
Zidovudine—SLC22A2—Metabolism—NT5C3A—bone cancer	4.92e-05	0.000547	CbGpPWpGaD
Zidovudine—ABCB1—Integrated Pancreatic Cancer Pathway—CHEK2—bone cancer	4.91e-05	0.000545	CbGpPWpGaD
Zidovudine—SLC22A2—Transmission across Chemical Synapses—BRAF—bone cancer	4.81e-05	0.000535	CbGpPWpGaD
Zidovudine—ABCC5—Disease—DHFR—bone cancer	4.74e-05	0.000527	CbGpPWpGaD
Zidovudine—CYP2C19—Biological oxidations—GSTP1—bone cancer	4.74e-05	0.000527	CbGpPWpGaD
Zidovudine—ALB—Transmembrane transport of small molecules—TUBB4B—bone cancer	4.73e-05	0.000526	CbGpPWpGaD
Zidovudine—TERT—Cell Cycle—TP53—bone cancer	4.69e-05	0.000522	CbGpPWpGaD
Zidovudine—ALB—Selenium Micronutrient Network—PTGS2—bone cancer	4.68e-05	0.00052	CbGpPWpGaD
Zidovudine—CYP2C19—Metapathway biotransformation—GSTP1—bone cancer	4.68e-05	0.00052	CbGpPWpGaD
Zidovudine—ABCB1—HIF-1-alpha transcription factor network—JUN—bone cancer	4.65e-05	0.000517	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—NT5C3A—bone cancer	4.52e-05	0.000502	CbGpPWpGaD
Zidovudine—CYP3A4—Tryptophan metabolism—MDM2—bone cancer	4.4e-05	0.000489	CbGpPWpGaD
Zidovudine—CYP2C9—Biological oxidations—GSTP1—bone cancer	4.32e-05	0.00048	CbGpPWpGaD
Zidovudine—ABCC5—Metabolism—ENO2—bone cancer	4.28e-05	0.000476	CbGpPWpGaD
Zidovudine—CYP2C9—Metapathway biotransformation—GSTP1—bone cancer	4.26e-05	0.000474	CbGpPWpGaD
Zidovudine—TERT—Disease—MDM2—bone cancer	4.2e-05	0.000466	CbGpPWpGaD
Zidovudine—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—bone cancer	4.16e-05	0.000462	CbGpPWpGaD
Zidovudine—ABCB1—Transmembrane transport of small molecules—TUBB4B—bone cancer	4.15e-05	0.000461	CbGpPWpGaD
Zidovudine—ALB—Transmembrane transport of small molecules—TUBB2A—bone cancer	4.09e-05	0.000454	CbGpPWpGaD
Zidovudine—TERT—Disease—PTGS2—bone cancer	4.05e-05	0.00045	CbGpPWpGaD
Zidovudine—SLC22A2—Transmission across Chemical Synapses—MDM2—bone cancer	4.03e-05	0.000448	CbGpPWpGaD
Zidovudine—ABCC5—Metabolism—DHFR—bone cancer	3.97e-05	0.000441	CbGpPWpGaD
Zidovudine—ABCC4—Hemostasis—PLAU—bone cancer	3.78e-05	0.00042	CbGpPWpGaD
Zidovudine—TK1—Metabolism—PTGS2—bone cancer	3.75e-05	0.000416	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—KIT—bone cancer	3.73e-05	0.000415	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—NDUFA12—bone cancer	3.72e-05	0.000414	CbGpPWpGaD
Zidovudine—ABCC5—Metabolism—GNA11—bone cancer	3.71e-05	0.000413	CbGpPWpGaD
Zidovudine—ALB—Metabolism—NDUFA12—bone cancer	3.7e-05	0.000411	CbGpPWpGaD
Zidovudine—SLC22A2—Neuronal System—BRAF—bone cancer	3.69e-05	0.00041	CbGpPWpGaD
Zidovudine—ABCB1—Transmembrane transport of small molecules—TUBB2A—bone cancer	3.58e-05	0.000398	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—BRAF—bone cancer	3.51e-05	0.00039	CbGpPWpGaD
Zidovudine—ALB—Folate Metabolism—TP53—bone cancer	3.5e-05	0.000389	CbGpPWpGaD
Zidovudine—ABCC5—Disease—TGFBR2—bone cancer	3.44e-05	0.000382	CbGpPWpGaD
Zidovudine—ABCC5—Metabolism—CYP3A4—bone cancer	3.37e-05	0.000374	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—NDUFA12—bone cancer	3.32e-05	0.000369	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—NDUFA12—bone cancer	3.24e-05	0.00036	CbGpPWpGaD
Zidovudine—UGT2B7—Metabolism—ENO2—bone cancer	3.16e-05	0.000351	CbGpPWpGaD
Zidovudine—ALB—Hemostasis—SPARC—bone cancer	3.14e-05	0.000349	CbGpPWpGaD
Zidovudine—SLC22A2—Neuronal System—MDM2—bone cancer	3.09e-05	0.000343	CbGpPWpGaD
Zidovudine—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—bone cancer	3.08e-05	0.000343	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—NT5C3A—bone cancer	3.08e-05	0.000343	CbGpPWpGaD
Zidovudine—ALB—Metabolism—NT5C3A—bone cancer	3.07e-05	0.000341	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—NDUFA12—bone cancer	3.03e-05	0.000337	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—MDM2—bone cancer	2.94e-05	0.000327	CbGpPWpGaD
Zidovudine—UGT2B7—Metabolism—DHFR—bone cancer	2.93e-05	0.000325	CbGpPWpGaD
Zidovudine—ABCC5—Metabolism—GSTP1—bone cancer	2.88e-05	0.00032	CbGpPWpGaD
Zidovudine—ALB—Hemostasis—GNA11—bone cancer	2.87e-05	0.000319	CbGpPWpGaD
Zidovudine—TERT—Disease—EGFR—bone cancer	2.87e-05	0.000319	CbGpPWpGaD
Zidovudine—CYP3A4—Biological oxidations—GSTP1—bone cancer	2.85e-05	0.000317	CbGpPWpGaD
Zidovudine—CYP3A4—Metapathway biotransformation—GSTP1—bone cancer	2.81e-05	0.000312	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—NT5C3A—bone cancer	2.75e-05	0.000306	CbGpPWpGaD
Zidovudine—UGT2B7—Metabolism—GNA11—bone cancer	2.74e-05	0.000304	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—NT5C3A—bone cancer	2.69e-05	0.000299	CbGpPWpGaD
Zidovudine—ALB—Hemostasis—IL3—bone cancer	2.6e-05	0.000289	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—JUN—bone cancer	2.55e-05	0.000284	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—NT5C3A—bone cancer	2.51e-05	0.000279	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—MMP9—bone cancer	2.49e-05	0.000276	CbGpPWpGaD
Zidovudine—UGT2B7—Metabolism—CYP3A4—bone cancer	2.48e-05	0.000276	CbGpPWpGaD
Zidovudine—ABCC5—Disease—KIT—bone cancer	2.35e-05	0.000261	CbGpPWpGaD
Zidovudine—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—bone cancer	2.29e-05	0.000254	CbGpPWpGaD
Zidovudine—ABCC5—Disease—BRAF—bone cancer	2.21e-05	0.000245	CbGpPWpGaD
Zidovudine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—bone cancer	2.2e-05	0.000245	CbGpPWpGaD
Zidovudine—ABCG2—Metabolism—ENO2—bone cancer	2.18e-05	0.000242	CbGpPWpGaD
Zidovudine—SLC22A2—Metabolism—ENO2—bone cancer	2.15e-05	0.000239	CbGpPWpGaD
Zidovudine—UGT2B7—Metabolism—GSTP1—bone cancer	2.12e-05	0.000236	CbGpPWpGaD
Zidovudine—ABCG2—Metabolism—DHFR—bone cancer	2.02e-05	0.000224	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—EGFR—bone cancer	2.01e-05	0.000223	CbGpPWpGaD
Zidovudine—SLC22A2—Metabolism—DHFR—bone cancer	2e-05	0.000222	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—NDUFA12—bone cancer	2e-05	0.000222	CbGpPWpGaD
Zidovudine—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—bone cancer	1.99e-05	0.000221	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—ENO2—bone cancer	1.98e-05	0.00022	CbGpPWpGaD
Zidovudine—ABCG2—Metabolism—GNA11—bone cancer	1.89e-05	0.00021	CbGpPWpGaD
Zidovudine—SLC22A2—Metabolism—GNA11—bone cancer	1.87e-05	0.000208	CbGpPWpGaD
Zidovudine—ABCC5—Disease—MDM2—bone cancer	1.85e-05	0.000205	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—DHFR—bone cancer	1.83e-05	0.000204	CbGpPWpGaD
Zidovudine—ABCC5—Disease—PTGS2—bone cancer	1.78e-05	0.000198	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—GNA11—bone cancer	1.71e-05	0.000191	CbGpPWpGaD
Zidovudine—ABCG2—Metabolism—CYP3A4—bone cancer	1.71e-05	0.00019	CbGpPWpGaD
Zidovudine—ALB—Hemostasis—PLAU—bone cancer	1.71e-05	0.00019	CbGpPWpGaD
Zidovudine—SLC22A2—Metabolism—CYP3A4—bone cancer	1.69e-05	0.000188	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—TP53—bone cancer	1.69e-05	0.000187	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—NT5C3A—bone cancer	1.66e-05	0.000184	CbGpPWpGaD
Zidovudine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—bone cancer	1.56e-05	0.000174	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—CYP3A4—bone cancer	1.55e-05	0.000173	CbGpPWpGaD
Zidovudine—ABCC4—Hemostasis—TP53—bone cancer	1.52e-05	0.000169	CbGpPWpGaD
Zidovudine—ABCC5—Metabolism—PTGS2—bone cancer	1.49e-05	0.000166	CbGpPWpGaD
Zidovudine—ABCG2—Metabolism—GSTP1—bone cancer	1.46e-05	0.000163	CbGpPWpGaD
Zidovudine—SLC22A2—Metabolism—GSTP1—bone cancer	1.45e-05	0.000161	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—ENO2—bone cancer	1.35e-05	0.00015	CbGpPWpGaD
Zidovudine—ALB—Metabolism—ENO2—bone cancer	1.34e-05	0.000149	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—GSTP1—bone cancer	1.33e-05	0.000148	CbGpPWpGaD
Zidovudine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—bone cancer	1.31e-05	0.000146	CbGpPWpGaD
Zidovudine—ABCC5—Disease—EGFR—bone cancer	1.26e-05	0.00014	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—DHFR—bone cancer	1.25e-05	0.000139	CbGpPWpGaD
Zidovudine—ALB—Metabolism—DHFR—bone cancer	1.25e-05	0.000138	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—ENO2—bone cancer	1.21e-05	0.000134	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—ENO2—bone cancer	1.18e-05	0.000131	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—GNA11—bone cancer	1.17e-05	0.00013	CbGpPWpGaD
Zidovudine—ALB—Metabolism—GNA11—bone cancer	1.16e-05	0.000129	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—DHFR—bone cancer	1.12e-05	0.000124	CbGpPWpGaD
Zidovudine—UGT2B7—Metabolism—PTGS2—bone cancer	1.1e-05	0.000122	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—ENO2—bone cancer	1.1e-05	0.000122	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—DHFR—bone cancer	1.09e-05	0.000121	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—CYP3A4—bone cancer	1.06e-05	0.000118	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.06e-05	0.000117	CbGpPWpGaD
Zidovudine—ALB—Metabolism—CYP3A4—bone cancer	1.06e-05	0.000117	CbGpPWpGaD
Zidovudine—ALB—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.05e-05	0.000117	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—GNA11—bone cancer	1.05e-05	0.000116	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—GNA11—bone cancer	1.02e-05	0.000113	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—DHFR—bone cancer	1.02e-05	0.000113	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—GNA11—bone cancer	9.53e-06	0.000106	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—CYP3A4—bone cancer	9.48e-06	0.000105	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	9.43e-06	0.000105	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—CYP3A4—bone cancer	9.25e-06	0.000103	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—GSTP1—bone cancer	9.08e-06	0.000101	CbGpPWpGaD
Zidovudine—ALB—Metabolism—GSTP1—bone cancer	9.03e-06	0.0001	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—CYP3A4—bone cancer	8.64e-06	9.6e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	8.6e-06	9.56e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—GSTP1—bone cancer	8.11e-06	9.01e-05	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—GSTP1—bone cancer	7.91e-06	8.79e-05	CbGpPWpGaD
Zidovudine—ABCG2—Metabolism—PTGS2—bone cancer	7.58e-06	8.43e-05	CbGpPWpGaD
Zidovudine—SLC22A2—Metabolism—PTGS2—bone cancer	7.5e-06	8.34e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—GSTP1—bone cancer	7.39e-06	8.21e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—ENO2—bone cancer	7.25e-06	8.06e-05	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—PTGS2—bone cancer	6.89e-06	7.65e-05	CbGpPWpGaD
Zidovudine—ALB—Hemostasis—TP53—bone cancer	6.87e-06	7.63e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—DHFR—bone cancer	6.73e-06	7.48e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—GNA11—bone cancer	6.29e-06	6.99e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—GSTP1—bone cancer	4.88e-06	5.42e-05	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—PTGS2—bone cancer	4.71e-06	5.23e-05	CbGpPWpGaD
Zidovudine—ALB—Metabolism—PTGS2—bone cancer	4.68e-06	5.2e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—PTGS2—bone cancer	4.2e-06	4.67e-05	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—PTGS2—bone cancer	4.1e-06	4.56e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—PTGS2—bone cancer	3.83e-06	4.26e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—PTGS2—bone cancer	2.53e-06	2.81e-05	CbGpPWpGaD
